Profile: Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

16.09EUR
27 Feb 2015
Change (% chg)

€-0.17 (-1.05%)
Prev Close
€16.26
Open
€16.33
Day's High
€16.45
Day's Low
€15.69
Volume
352,405
Avg. Vol
246,082
52-wk High
€16.45
52-wk Low
€11.12

Search Stocks
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. In October 2013, the Company acquired a 100% stake in Laboratorios Casen Fleet SLU; and approximately 67% of the share capital of Opalia Pharma S.A., a Tunisian pharmaceutical company.

Company Address

Recordati Industria Chimica e Farmaceutica SpA

Via M. Civitali, 1
MILANO     20148
P: +3902.487871
F: +3902.40073747

Company Web Links

Search Stocks